Table 1.
Clinicopathological parameters |
Total | FGFR4 Expression | P | |
---|---|---|---|---|
Low | High | |||
Gender | 55 | 0.370 | ||
Male | 43 | 19 | 24 | |
Female | 12 | 4 | 8 | |
Age | 0.151 | |||
<50 | 14 | 8 | 6 | |
≥50 | 41 | 15 | 26 | |
Clinical stages | 0.038* | |||
1 | 2 | 2 | 0 | |
2 | 8 | 6 | 2 | |
3 | 29 | 11 | 18 | |
4 | 16 | 4 | 12 | |
Lymph node metastasis | 0.125 |
|||
N0-N1 | 18 | 10 | 8 | |
N2-N3 | 37 | 13 | 24 | |
Ki-67 expression | 0.047* | |||
low | 25 | 14 | 11 | |
high | 30 | 9 | 21 |
Statistical analyses were performed by the Pearson χ2 test. * P <0.05 was considered significant.